Contact

Click here for a confidential contact or call:

1-212-350-2774

The Antitrust Week in Review

The Antitrust Week In Review

Posted  04/5/24
Here are some of the developments in antitrust news this past week that we found interesting and are following.   Meta cannot delay US FTC from reopening privacy probe, court says.  Meta Platforms cannot delay the U.S. Federal Trade Commission from reopening a probe into alleged privacy failures by its Facebook unit while the company pursues a lawsuit challenging the agency's authority, a U.S. court ruled. The...

The Antitrust Week In Review

Posted  03/29/24
Here are some of the developments in antitrust news this past week that we found interesting and are following.   American Express sued in merchants' class-action over 'swipe' fees.  American Express has been hit with a proposed class action lawsuit in Rhode Island federal court accusing it of overcharging thousands of U.S. merchants for credit and debit card fees on consumer transactions. Ten retail plaintiffs...

The Antitrust Week In Review

Posted  02/20/24
Here are some of the developments in antitrust news this past week that we found interesting and are following.   On the Ground of Biden’s Antitrust Agenda.  Big deals are waiting on the tarmac as Wall Street and the business world anticipate how the presidential election will change antitrust enforcement. President Biden has taken an aggressive approach to policing deals that some have called overreaching...

The Antitrust Week In Review

Posted  01/24/24
Here are some of the developments in antitrust news this past week that we found interesting and are following.   Spirit Airlines Is on Shaky Footing After Judge Blocks JetBlue Deal.  Spirit Airlines, once a fast-growing low-cost carrier, is struggling to convince investors that it has a clear path forward after an antitrust ruling blocked the sale of the company to JetBlue Airways. A federal judge in Boston...

The Antitrust Week In Review

Posted  12/13/23
Here are some of the developments in antitrust news this past week that we found interesting and are following.   Smaller Airlines Seek Mergers to Compete With Industry Giants.  Smaller airlines that operate in the shadow of the nation’s four dominant air carriers are increasingly feeling pressure to merge with others to gain access to more planes and airport gates. Those dynamics were on display in a federal...

The Antitrust Week In Review

Posted  11/28/23
Here are some of the developments in antitrust news this past week that we found interesting and are following.   NCAA faces new lawsuit over athletes' drive for compensation.  The National Collegiate Athletic Association has been sued in Colorado federal court for allegedly depriving student players of billions of dollars in compensation from televised broadcasts of college athletics. Former University of...

The Antitrust Week In Review

Posted  11/20/23
Here are some of the developments in antitrust news this past week that we found interesting and are following. Tesla beats lawsuit claiming it monopolizes repairs, parts.  A U.S. judge dismissed an antitrust lawsuit accusing Elon Musk's electric car company Tesla of forcing customers to pay high prices and suffer long waits for repairs by monopolizing the markets for vehicle maintenance and replacement parts. In...

The Antitrust Week In Review

Posted  11/8/23
Here are some of the developments in antitrust news this past week that we found interesting and are following.   T-Mobile must face private antitrust lawsuit over $26 bln Sprint deal - US judge.  A federal judge in Chicago has ordered T-Mobile US to face a lawsuit from AT&T and Verizon subscribers who claim the mobile communication giant's deal for rival Sprint hurt competition and caused them to pay billions...

The Antitrust Week In Review

Posted  09/20/23
Here are some of the developments in antitrust news this past week that we found interesting and are following.   US FTC warns drugmakers over patent listings.  The U.S. Federal Trade Commission warned brand-name drugmakers they could face legal action if they improperly list patents with federal health regulators and said it will scrutinize any improper listings. "Improperly listing patents in the Orange Book...
1 2 3 4 43